Send us a link
The Lancet Changes Editorial Policy After Hydroxychloroquine Covid Study Retraction
The Lancet Changes Editorial Policy After Hydroxychloroquine Covid Study Retraction
New policy comes after serious quality control questions were raised about the data relied on by a study in the medical journal
COVID-19 Vaccines Could End Up With Bias Built Right In
Some of the leading candidates might work better for the richest people in the world, simply on account of how they're made.
The Lasting Misery of Coronavirus Long-haulers
Months after infection with SARS-CoV-2, some people are still battling crushing fatigue, lung damage and other symptoms of 'long COVID'.
Students Have Been Sold the Lie They Are Able to Have a Full University Experience. They Can't.
Students Have Been Sold the Lie They Are Able to Have a Full University Experience. They Can't.
The government and vice-chancellors have a duty of care, yet in too many colleges, Covid security is mere hygiene theatre.
Learning from a Retraction
The editors of the Lancet Group examined The Lancet's peer-review processes to identify ways of further reducing risks of research and publication misconduct.
First Report of the INGSA Evidence-to-Policy Tracker
The aim of the study is not to compare and assess the success of countries’ key Covid policy responses, but rather to compare the various ways in which evidence has been marshalled and applied.
Stillbirth Rate Rises Dramatically During Pandemic
Researchers stress need for antenatal care, as emerging data link disrupted pregnancy services to increase in stillbirths.
Researchers Highlight 'questionable' Data in Russian Coronavirus Vaccine Trial Results
Vaccine Transparency
Efforts to find and deploy a coronavirus vaccine should be as transparent as possible to increase the chances of success - but the reality is often sadly different.
Vaccine Makers Keep Safety Details Quiet, Alarming Scientists
Researchers say drug companies need to be more open about how vaccine trials are run to reassure Americans who are skittish about getting a coronavirus vaccine.
COVID-19 Herd Immunity: Where Are We?
During the current COVID-19 pandemic, the concept of herd immunity has become a topic of much debate. This Comment examines the factors that determine it, discusses how far we have come and considers what it will take to reach herd immunity safely.
Show More Empathy to Boost Confidence in Vaccines, Scientists Told
Expert behind vaccine confidence report points to halting of Oxford Covid trial as example.
What if We Have to Wait Years for a Coronavirus Vaccine?
A silver-bullet vaccine is far from guaranteed. But it's also not the only way out of the pandemic.
How the Coronavirus Attacks the Brain
It's not just the lungs - the pathogen may enter brain cells, causing symptoms like delirium and confusion, scientists reported.
Postdocs in Crisis: Science Cannot Risk Losing the Next Generation
Postdocs in Crisis: Science Cannot Risk Losing the Next Generation
The pandemic has worsened the plight of postdoctoral researchers. Funders need to be offering more than moral support.
Open Access in the Plague Year
Coronavirus shows why open publishing is vital, but could make it unaffordable, says Martin Eve.
Facts V Feelings: How to Stop Our Emotions Misleading Us
Facts V Feelings: How to Stop Our Emotions Misleading Us
The pandemic has shown how a lack of solid statistics can be dangerous. But even with the firmest of evidence, we often end up ignoring the facts we don't like.
The Contagion Externality of a Superspreading Event:The Sturgis Motorcycle Rally and COVID-19
The Contagion Externality of a Superspreading Event:The Sturgis Motorcycle Rally and COVID-19
Large in-person gatherings without social distancing and with individuals who have traveled outside the local area are classified as the “highest risk” for COVID-19 spread by the Centers for Disease Control and Prevention (CDC). Between August 7 and August 16, 2020, nearly 500,000 motorcycle enthusiasts converged on Sturgis, South Dakota for its annual motorcycle rally.
Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine
Universal facial masking might help reduce the severity of SARS-CoV-2 and ensure that a greater proportion of new infections are asymptomatic.
GII 2020: COVID-19 Impact on Global Innovation; Annual Ranking Topped by Switzerland, Sweden, U.S., U.K. and Netherlands
GII 2020: COVID-19 Impact on Global Innovation; Annual Ranking Topped by Switzerland, Sweden, U.S., U.K. and Netherlands
The COVID-19 pandemic is severely pressuring a long-building rise in worldwide innovation, likely hindering some innovative activities while catalyzing ingenuity elsewhere, notably in the health sector, according to the Global Innovation Index (GII) 2020.
The FBI Is Warning Scientists To Watch Out For "Suspicious" Packages
After COVID-19 researchers on the East Coast received a package containing an "unknown substance," the University of Washington told 500 of its staff to be on alert.
Let's Get Real. No Vaccine Will Work As if by Magic, Returning Us to 'normal'
COVID-19's Indirect Attack on Women
EMBL will hold a virtual conference, 'The impact of the COVID-19 crisis on women in science: Challenges and solutions' on 9 September.
A New Front in America's Pandemic: College Towns
The coronavirus is spiking around campuses from Texas to Iowa to North Carolina as students return.